Clinical research with traditional herbal medicinesEvidence-based medicine (EBM) is the new nostrum, and the randomised controlled trial (RCT) is the chosen device for buttressing its evidence base. Evidence, in the context of decision-making about therapeutic interventions, serves one purpose: it is the medium of establishing their efficacy for clinicians involved in the care of patients' life and health, and their rightness for experts charged with the responsibility for taking decisions with regard to therapeutic guidelines, public health interventions and health care systems.The long-standing dispute about the nature of science and scientific method, with respect to the inductive and deductive approaches to scientific knowledge, continues unabated. Recent attempts to stratify evidence into hierarchies based on 'levels' of sources and perceptions of quality have intensified the controversy pertaining to the relative merits of experimentation versus observation in the domain of modern therapeutics. The Scottish Intercollegiate Guideline Network (SIGN) is a typical example of a hierarchy of evidence [1]. All hierarchies place RCTs at the pinnacle, with observational studies languishing in the lower regions, and 'expert opinion' at the bottom. Hierarchies of evidence are now widely regarded as reliable measures of relative 'strength' of evidence in therapeutics, and used -particularly by committees that develop guidelines -to rank therapeutic interventions' merit, based on their perceived robustness. There is no gainsaying of course that popular acceptance of EBM has transformed medical practice and research preponderantly for the better, but the widespread and mechanical use of hierarchies of evidence has also raised many questions [2]. The findings of a single RCT or a systematic review of several will give evidence about the efficacy of an intervention (ie. 'the particular treatment has worked somewhere'), very often without supplying testimony regarding its clinical effectiveness in actual practice (ie. 'the treatment works extensively'), or its efficiency (ie. 'is it worth it?') [3,4,5].Most RCTs test efficacy with carefully selected patients, numerous exclusion criteria, absence of co-morbidities, intensely supervised treatment, monitored patient compliance and careful follow up -ideal conditions rarely available in actual clinical practice in which effectiveness and efficiency are important considerations [3,5,6]. RCT evidence is often not generalisable to certain groups of people, individuals, or different settings. Often RCT evidence also fades with time. To choose one example from the many available, older antipsychotic medications have been shown in large well-designed trials to be as effective as the newer ones (eg. olanzepine, risperidone etc.), and cost much less, alas! after widespread prescription of the newer drugs had made fortunes for their manufacturers [2].Among the large number of distinguished clinicians and scientists who have expressed serious misgivings about such hierarchies of evidenc...